Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Sartorius AG    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

SARTORIUS VORZUEGE : NorldLB Upgrades to Neutral

04/22/2020 | 08:25am EST
share with twitter
share with LinkedIn
share with facebook

NorldLB's analyst Volker Sack upgrades the rating on the company from Sell to Neutral. The target price has been raised from EUR 150 to EUR 238.


© MarketScreener with dpa-AFX Analyser 2020
All news about SARTORIUS AG
01/15SARTORIUS : Partners With RoosterBio to Advance Cell and Gene Therapy Manufactur..
PU
01/06SARTORIUS : to acquire Novasep's chromatography process equipment...
PU
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 -2-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -3-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -2-
DJ
01/04SARTORIUS VORZUEGE : Receives a Buy rating from JP Morgan
MD
01/04SARTORIUS STEDIM BIOTECH SA : Declaration relative to the number of shares and v..
DJ
2020SARTORIUS : and Evotec Partner With Start-up Curexsys on IPSC-Based...
PU
2020PRESS RELEASE : Evotec and sartorius partner with -2-
DJ
2020SARTORIUS : pays employees a coronavirus bonus
PU
More news
Financials
Sales 2020 2 305 M 2 785 M 2 785 M
Net income 2020 233 M 282 M 282 M
Net Debt 2020 1 759 M 2 125 M 2 125 M
P/E ratio 2020 114x
Yield 2020 0,23%
Capitalization 24 626 M 29 774 M 29 754 M
EV / Sales 2020 11,4x
EV / Sales 2021 9,60x
Nbr of Employees 10 008
Free-Float 46,8%
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 246,58 €
Last Close Price 345,00 €
Spread / Highest target 1,74%
Spread / Average Target -28,5%
Spread / Lowest Target -80,1%
EPS Revisions
Managers and Directors
NameTitle
Joachim Kreuzburg Chief Executive Officer
Lothar Kappich Chairman-Supervisory Board
Volker Niebel Head-Production, Procurement & Business Operations
Rainer Lehmann Chief Financial Officer
Oscar-Werner Reif Head-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SARTORIUS AG0.00%29 774
REVENIO GROUP OYJ-2.88%1 567
ALPHATEC HOLDINGS, INC.-1.86%1 118
CELLAVISION AB (PUBL)1.24%885
VAREX IMAGING CORPORATION10.67%723
OXFORD IMMUNOTEC GLOBAL PLC25.62%570
Categories
Free services
Mobile App
SOLUTIONS
About
Stock Market Quotes Interactive brokers The best of tweets Stock Market News Börse: Aktien, Kurse und Nachrichten
Copyright © 2021 Surperformance. All rights reserved. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ